Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: Diagnosis of small intestinal neuroendocrine tumors (SI-NETs) is often delayed due to non-specific symptoms and lack of awareness among primary and secondary care physicians. Earlier diagnosis may lead to improved clinical and patient outcomes. Clinical prediction models using machine learning could present novel opportunities for expedited diagnosis in primary care.
Conference:
Presenting Author:
Authors: Clift A, Mahon H, Khan G, Boardman-Pretty F, Worker A,
Keywords: machine learning, artificial intelligence, diagnosis, neuroendocrine tumor,
Introduction: Patient Initiated Follow Up (PIFU) is well established in this regional cancer centre, it allows patients to contact a cancer specialist team based on symptoms and individual circumstances. Patients are empowered to manage follow-up remotely, undertaking cancer surveillance tests and accessing results through the digital system MyMedicalRecord (MyMR).
Conference:
Presenting Author:
Authors: Ramsey E, Marsh C, Jarvis E, Armstrong T, Knight J,
Keywords: surveillance, Patient-initiated follow-up, neuroendocrine tumor, follow-up,
Introduction: The outcome of the primary lung neuroendocrine tumors (L-NETs) surgery at metastatic stage remains poorly characterized.
Conference:
Presenting Author: Walter T
Authors: Duponchelle L, Baudin E, Do Cao C, Dansin E, Perrier M,
Keywords: lung, neuroendocrine tumor, carcinoid, metastatic, prognosis, surgery,
Introduction: Due to financial incapability and absence of manpower poor families often fail to carry their advanced cancer patients to the nodal centres.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Mandal N,
Keywords: cancer,
#2686 Survivorship Care Model for Patients with Metastatic Neuroendocrine Tumors
Introduction: Neuroendocrine tumors(NET)are rare often indolent tumors. Approximately 22% of patients (pt's) present with metastatic disease at diagnosis and can live with metastatic disease for years. These pt's often don't identify as cancer survivors and don't meet the criteria for care in traditional survivorship clinics
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Laffan A
Authors: Laffan A,
Keywords: neuroendocrine, survivorship, multidisciplinary, metastatic,